Decreased hemoglobin levels are associated with higher plasma level of fibrinogen, irrespective of age

American Journal of the Medical Sciences

Volumn 333, Issue 3, 2007, Pages 154-160

  Coppola, Ludovico ^a,b   Guastafierro, Salvatore ^a   Sagristani, Marco ^a   Coppola, Antonino ^a   Nasuti, Adele ^a   Ruggiero, Luigi ^a   De Biase, Maria ^a   Tirelli, Angelo ^a   Gombos, Giorgio ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Department of Geriatrics and Metabolic Diseases ^*  (Italy)

Author keywords

Aging; Blood rheology; Fibrinogen; Hemoglobin; Platelet

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; GLUCOSE; HEMOGLOBIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; BLOOD VISCOSITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE COUNT; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MULTIPLE REGRESSION; PATHOPHYSIOLOGY; POST HOC ANALYSIS; POSTMENOPAUSE; PREMENOPAUSE; PROTEIN BLOOD LEVEL; SEX RATIO; STANDARD; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD CELL COUNT; BLOOD CHEMICAL ANALYSIS; FEMALE; FIBRINOGEN; HEMATOCRIT; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SEX FACTORS;

EID: 34547552244     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3180312547     Document Type: Article

References (38)

1. Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischemic heart disease: principal results of the Northwick Park heart study. Lancet 1986;2:533-7.
2. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a metanalysis and review of the literature. Ann Intern Med 1993;118:956-63.
3. Heinrich J, Balleisen L, Schulte W, et al. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 1994;14:54-9.
4. Woodward M, Lowe GD, Rumley A, et al. Fibrinogen as risk factor for coronary heart disease and mortality in middleage men and women. The Scottish Heart Health Study. Eur Heart J 1998;19:55-62.
5. Ma J, Hennekens CH, Ridker PM, et al. A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study. J Am Coll Cardiol 1999;33:1347-52.
6. Maresca G, Di Blasio A, Marchioli R, et al. Measuring plasma fibrinogen to predict stroke and myocardial infraction. An update. Arterioscler Thromb Vasc Biol 1999;19:1368-77.
7. Bielak LF, Klee GG, Sheedy PF II, et al. Association of fibrinogen with quantity of coronary artery calcification measured by electron beam computed tomography. Arterioscler Thromb Vasc Biol 2000;20:2167-71.
8. Blake G, Schmitz C, Lindpaintner K, et al. Mutation in the promoter region of the beta-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis. Eur Heart J 2001;22:2262-6.
9. Cantin B, Despres JP, La marche B, et al. Association of fibrinogen and lipoprotein (a) as a coronary heart disease factor in men (The Quebec Cardiovascular Study). Am J Cardiol 2002;89:662-6.
10. Chien S. Haemorheology in disease: pathophysiological significance and therapeutic implications. Clin Hemorheol 1981;1:419-42.
11. Danesh J, Collins R, Peto R, et al. Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. Eur Heart J 2000;21:5151-520.
12. Humphries SE, Cook M, Dubowitz M, et al. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet 1987;1:1452-5.
13. Iso H, Folsom AR, Winkelmann JC. Polimorphisms of the beta fibrinogen gene and plasma fibrinogen concentration in Caucasian and Japanese population samples. Thromb Haemost 1995;73:106-11.
14. Margaglione M, Cappucci G, Colaizzo D, et al. Fibrinogen plasma level in an apparently healthy general population. Relation to environmental and genetic determinants. Thromb Haemost 1998;80:805-10.
15. Krobot K, Hense HW, Cremer P, et al. Determinants of plasma fibrinogen: relation to body weight waist to hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg survey 1989-1990. Arterioscler Thromb 1992;12:780-8.
16. Halle M, Berg A, Keul J, et al. Association between serum fibrinogen concentrations and HDL and LDL lipoprotein subfraction phenotypes in healthy men. Arterioscler Thromb Vasc Biol 1996;16:144-8.
17. De Pergola G, De Mitrio V, Sciaraffia M, et al. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men. Metabolism 1997;46:1287-93.
18. James S, Vorster HH, Venter CS, et al. Nutritional status influence plasma fibrinogen concentration: evidence from the THUSA survey. Thromb Res 2000;98:383-94.
19. Steptoe A, Kunz-Ebrecht S, Owen N, et al. Influence of socioeconomic status and job control on plasma fibrinogen responses to acute mental stress. Psychosom Med 2003;65:137-44.
20. Bo M, Raspo S, Morra F, et al. Body fat is the main predictor of fibrinogen levels in healthy non-obese men. Metabolism 2004;53:984-908.
21. De Maat MPM. Effects of diet, drugs, and genes on plasma fibrinogen levels. Ann NY Acad Sci 2001;936:509-21.
22. Coppola L, Caserta F, De Lucia D, et al. Blood viscosity and aging. Arch Gerontol Geriatr 2000;31:35-42.
23. Resnick NM. Geriatric Medicine. In: Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 1998:39-46.
24. Clauss A. Gerinnungs physiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957;17:237-46.
25. Laharrague PF, Cambus JP, Fillola G, et al. Plasma fibrinogen and physiological aging. Aging Clin Exper 1993;5:445-9.
26. Cavestri R, Radice L, Ferrarini F, et al. Influence of erythrocyte aggregability and plasma fibrinogen concentration on CBF with aging. Acta Neurol Scand 1992;85:292-8.
27. Barasch E, Benderly M, Graff E, et al. Plasma fibrinogen levels and their correlate in 6457 coronary heart diseases patients. The Bezafibrate Infarction Prevention (BIF) study. J Clin Epidemiol 1995;48:757-65.
28. Ko GT, Yeung VT, Chan JC, et al. Plasma fibrinogen concentration in a Chinese population. Artherosclerosis 1997;131:211-7.
29. Maher JT, Levine PH, Cymerman A. Human coagulation abnormalities during acute exposure to hypobaric hypoxia. J Appl Physiol 1976;41:702-7.
30. Rupert JL, Devine DV, Monsalve MV, et al. Beta-fibrinogen allele frequencies in Peruviam Quechua, a high-altitude native population. Am J Phys Antropol 1999;109:181-6.
31. Rupert JL, Monsalve MV, Kidd KK, et al. Selective pressure has not acted against hypercoagulability alleles in high-altitude Amerindians. Ann Hum Genet 2003;67:426-32.
32. Mandai R, Eguchi Y, Tanaka M, et al. Effects of profound hemodilution on small-intestinal wound healing in rabbits. J Surg Res 2001;99:107-13.
33. Beguin Y, Loo M, R'Zirk S, et al. Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrrin receptor and fibrinogen. Blood 1993;7:2010-6.
34. Coppola L, Guastafierro S, Grimaldi R, et al. Donazioni di sangue e livelli plasmatici di fibrinogeno. Atti Giornate Scientifiche della Seconda Università di Napoli 2002;235-6.
35. Breddin HK, Lippod R, Bittner M, et al. Spontaneous platelet aggregation as a predictive risk factor for vascular occlusions in healthy volunteers? Results of the HARPAG Study. Haemostatic parameters as risk factors in healthy volunteers. Atherosclerosis 1999;144:211-9.
36. Meade TW. Fibrinogen in ischaemic heart disease. Eur Heart J 1995;16(suppl A):31-4.
37. Vazquez-Chavez C, Salinas-Orozco S, Gomez-Diaz RA, et al. Effects of bezafibrate in the diet of hypertensive patients with dyslipidemia and hyperfibrinogenemia. Rev Invest Clin 1998;50:491-6.
38. Wierzbicki AS, Lumb PJ, Chik G, et al. Fibrinogen response with simvastatin versus atorvastatin in familial hypercholesterolemia. Am J Cardiol 2001;338-40.